Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002250341 | SCV002519711 | pathogenic | Congenital dyserythropoietic anemia, type II | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481053 | SCV002799362 | pathogenic | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2022-02-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002481053 | SCV004568815 | pathogenic | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2023-08-23 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs775380378, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Arg123*) in the SEC23B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SEC23B are known to be pathogenic (PMID: 19561605, 25044164). This premature translational stop signal has been observed in individual(s) with congenital dyserythropoietic anemia type II (PMID: 20941788, 22208203). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1686174). |